+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Rosacea Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Pre Book Price: $ 5216

Original Price: $ 5795

Rosacea Therapeutics Market: Overview  

The American Academy of Dermatology states that over 14 million people are currently living with rosacea in the U.S. alone. The Canadian Dermatology Association reports that this chronic skin condition affects over two million people in the country, while the British Skin Foundation finds that more than eight million people in the U.K. suffer from various skin conditions, including rosacea. The rising incidence of this skin disease has greatly boosted the demand for rosacea therapeutics.

Rosacea can be of four types: papulopustular rosacea, erythematotelangiectatic rosacea, ocular rosacea, and phymatous rosacea. Symptoms of this condition range from redness in the face and flushing of the skin to swelling and acne-like breakouts. Considering that rosacea does not resolve on its own, there are a number of therapeutic options recommended by dermatologists. These include topical agents such as Metronidazole and Tretinoin; antibiotics, which can be both oral and topical; steroid creams; oral agents such as Isotretinoin; sulfur and sodium sulfacetamide; camouflage make-up; and cosmetic surgeries such as laser therapy.

The report studies the various segments and sub-segments in depth and offers a detailed assessment of their current, historical, and future performance. The factors driving and hampering the rosacea therapeutics market and recommendations on how to overcome the challenges have also been highlighted in the study. With the help of the latest industry tools, such as Porter’s Five Forces analysis model, SWOT analysis, value chain analysis, and market attractiveness, readers are given a 360-degree overview of where the rosacea therapeutics market stands today and where it is headed in the coming years.

Rosacea Therapeutics Market: Trend and Opportunities 

Rosacea has been a common yet rather poorly understood skin disorder and this has, in the past, limited the scope of the rosacea therapeutics market. However, as the condition became increasingly widespread across the North American and European regions, patients have become more aware of the signs and symptoms. The growing penetration of smartphones and the Internet enables the quick, easy, and effective dissemination of information and this has also contributed significantly to the growing awareness levels. As a result, the uptake of rosacea therapeutics has received a boost.

Personal appearance is important to almost every individual and the social, psychological, and occupational side effects of rosacea also form a key factor driving the global rosacea therapeutics market. In a survey conducted by the National Rosacea Society in the U.S., it was found that over 90.0% of the patients afflicted by this chronic skin ailment suffered from low self-esteem and self-confidence. The survey also found that rosacea has adversely impacted the professional as well as social interactions of the patient. The rising emotional burden of this condition has therefore led to the decision of opting for therapeutic treatment. 

Rosacea Therapeutics Market: Region-wise Outlook

The global market for rosacea therapeutics can be geographically segmented into North America, Europe, Asia Pacific, and Rest of the World. North America and Europe presently dominate the overall market, powered primarily by the U.S. The National Institutes of Health states that rosacea is a condition more common in people of western and northern European descent and as a result is prevalent mostly in the European Union and the U.S. There is a high level of awareness among end users as well as patients regarding rosacea and its various treatment options and this has significantly driven the uptake of rosacea therapeutics in Europe and North America. Greater purchasing power and higher expenditure on healthcare have also contributed to the growth of these regional markets. Better product availability and an increasing number of companies investing in the field also bode well for the rosacea therapeutics market in North America and Europe.

The Asia Pacific rosacea therapeutics market is likely to expand at a rapid pace over the coming years and offers key players lucrative opportunities. Despite the fact that the awareness level regarding the skin condition is lower in this region than in developed regions, the market holds immense promise owing to a massive consumer base. This, in addition to a thriving medical tourism industry, has attracted manufacturers from around the world to invest in the APAC rosacea therapeutics market.

Companies mentioned in the research report  

Players making a significant contribution to the rosacea therapeutics market include Delenex Therapeutics AG, TWi Pharmaceuticals, Inc., Merz Pharma GmbH & Co. KgaA, Foamix Pharmaceuticals Ltd., Hovione FarmaCiencia SA, Valeant Pharmaceuticals International, Inc., Promius Pharma, LLC, Allergan Plc, and Amorepacific Corporation.

This report gives you access to decisive data such as:

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for the coming years

Key highlights of this report

  • Overview of key market forces propelling and restraining market growth
  • Up-to-date analyses of market trends and technological improvements
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors
  • An array of graphics and SWOT analysis of major industry segments
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis
  • Offers a clear understanding of the competitive landscape and key product segments

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market  
     

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.


Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.


To receive discount, please click on the button below.

Please click on the button below to customize this report.

 
 
Back To Top